4.5 Review

Clinical aspects of Alzheimer's disease

Journal

CLINICAL BIOCHEMISTRY
Volume 72, Issue -, Pages 3-6

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2019.04.015

Keywords

Alzheimer's disease; Dementia; Plaques; Tangles Beta amyloid; Tau protein; Clinical aspects

Funding

  1. project Novel blood-based biomarkers for early diagnosis, prognosis and progress of Alzheimer's disease (GA CR, Czech Republic) [17-05292S]
  2. project Neuropsychiatric aspects of neurodegenerative disorders (Progres Q27/LF1) by Charles University in Prague

Ask authors/readers for more resources

Alzheimer's disease is a progressive, irreversible, incurable, neurodegenerative illness and the most common of the dementing disorders. It starts usually after 60 years of age and may span 8 to 12 years. The continuous and slow decline caused by this disease, is characterized by cognitive deterioration, loss of functional independence, changes in behaviour, and expanding needs for care. In the last three decades, the proteins predominating neuritic plaques and neurofibrillary tangles have been detected and researched: amyloid-beta protein in the plaques and hyperphosphorylated tau in the tangles. Alzheimer's disease is now considered a long-term process with a slow progress and with a prolonged development of pathological changes that precedes symptoms by years. AD is becoming one of the most problematic and expensive illness for the civilization, also known as silent threat.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available